Basic Information | |
---|---|
Species | Glycine max |
Cazyme ID | Glyma19g29020.3 |
Family | GT47 |
Protein Properties | Length: 476 Molecular Weight: 54950.9 Isoelectric Point: 9.5813 |
Chromosome | Chromosome/Scaffold: 19 Start: 36588997 End: 36592411 |
Description | Exostosin family protein |
View CDS |
External Links |
---|
NCBI Taxonomy |
Plaza |
CAZyDB |
Signature Domain Download full data set without filtering | |||
---|---|---|---|
Family | Start | End | Evalue |
GT47 | 143 | 419 | 0 |
RSLKIYVYPHREDDPFANVLLPVESEPGGNYTSESYFKKVLMKSHFITKDPPEADLFFLPFSMARLWHDRRVGVGGIQDFIRDYIHNISHRYPYWNNTGG ADHFYVACHSIGRSAMDKAPDEKFNAIQVVCSSSYFLTGYFAHKDACLPQIWPRKGNPPNLVSSKRKRLAFFAGGVNSPVRVKLLETWKNDSEIFVHHGR LKTPYADELLGSKFCLHVKGFEVNTARIGDSLYYGCVPVIIANYYDLPFADVLNWKSFSVVVTTLDIPLLKKILKDI |
Full Sequence |
---|
Protein Sequence Length: 476 Download |
MVRSSLLYYY SQRRLAGSFR GFFFIPTTLA LFTSFFILFY IYSTSNIFTH HNHHPSTSHF 60 KPHPPFSTTP FIATTPHFVP VFNHNASEST KSPPTFQLGY GLGPQSQRGL PLPPQFSSKG 120 KFENNDVFHD RDVFLEDYKE MNRSLKIYVY PHREDDPFAN VLLPVESEPG GNYTSESYFK 180 KVLMKSHFIT KDPPEADLFF LPFSMARLWH DRRVGVGGIQ DFIRDYIHNI SHRYPYWNNT 240 GGADHFYVAC HSIGRSAMDK APDEKFNAIQ VVCSSSYFLT GYFAHKDACL PQIWPRKGNP 300 PNLVSSKRKR LAFFAGGVNS PVRVKLLETW KNDSEIFVHH GRLKTPYADE LLGSKFCLHV 360 KGFEVNTARI GDSLYYGCVP VIIANYYDLP FADVLNWKSF SVVVTTLDIP LLKKILKDII 420 SSNKYLMLQS NVLKVRKHFQ WHSPPQDFDA FYMVMYELWL RRSSIKNTWV DSFRV* 480 |
Functional Domains Download unfiltered results here | ||||||||
---|---|---|---|---|---|---|---|---|
Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
pfam03016 | Exostosin | 2.0e-65 | 141 | 404 | 281 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. |
Gene Ontology | |
---|---|
GO Term | Description |
GO:0016020 | membrane |
Annotations - NR Download unfiltered results here | |||||||
---|---|---|---|---|---|---|---|
Source | Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
GenBank | ABD28410.1 | 0 | 1 | 465 | 1 | 479 | Exostosin-like [Medicago truncatula] |
EMBL | CBI39073.1 | 0 | 1 | 466 | 1 | 444 | unnamed protein product [Vitis vinifera] |
RefSeq | XP_002265438.1 | 0 | 1 | 466 | 1 | 442 | PREDICTED: hypothetical protein [Vitis vinifera] |
RefSeq | XP_002325425.1 | 0 | 141 | 466 | 1 | 321 | predicted protein [Populus trichocarpa] |
RefSeq | XP_002525728.1 | 0 | 141 | 469 | 1 | 328 | catalytic, putative [Ricinus communis] |
Metabolic Pathways | |||
---|---|---|---|
Pathway Name | Reaction | EC | Protein Name |
xylogalacturonan biosynthesis | RXN-9589 | EC-2.4.2.41 | xylogalacturonan β-1,3-xylosyltransferase |